Literature DB >> 1645846

Hepatitis C virus in fulminant hepatic failure.

M Yanagi, S Kaneko, M Unoura, S Murakami, K Kobayashi, J Sugihara, H Ohnishi, Y Muto.   

Abstract

Entities:  

Mesh:

Year:  1991        PMID: 1645846     DOI: 10.1056/NEJM199106273242615

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

Review 1.  The quasispecies of hepatitis C virus and the host immune response.

Authors:  P Farci; J Bukh; R H Purcell
Journal:  Springer Semin Immunopathol       Date:  1997

Review 2.  Hepatitis C virus: molecular biology and genetic variability.

Authors:  C Bréchot
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

3.  Genotype of hepatitis C virus in fulminant hepatitis C.

Authors:  M Yoshiba; K Sekiyama; K Inoue; F Sugata; H Okamoto
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

4.  Porphyria cutanea tarda and hepatitis C virus infection in a patient with acute liver failure.

Authors:  R M Jasmer; M S Larson; K N Weilbaecher
Journal:  West J Med       Date:  1994-11

Review 5.  Acute hepatic failure: limitations of medical treatment and indications for liver transplantation.

Authors:  M Peters; K H Meyer zum Büschenfelde; G Gerken
Journal:  Clin Investig       Date:  1993-11

6.  Prospective assessment of incidence of fulminant hepatitis in post-transfusion hepatitis: a study of 504 cases.

Authors:  S Takano; M Omata; M Ohto; Y Satomura
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

7.  Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis.

Authors:  D Mutimer; J Shaw; J Neuberger; S Skidmore; B Martin; S Hubscher; P McMaster; E Elias
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

8.  Interferon and cyclosporin A in the treatment of fulminant viral hepatitis.

Authors:  M Yoshiba; K Sekiyama; K Inoue; R Fujita
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

9.  Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection.

Authors:  G N Dalekos; K Achenbach; D Christodoulou; G K Liapi; E K Zervou; D A Sideris; E V Tsianos
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

10.  Lack of evidence for hepatitis B virus (HBV) infection in fulminant non-A, non-B hepatitis.

Authors:  T Laskus; J Rakela; R H Wiesner; J L Steers; D H Persing
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.